Here's why shares in Challenger Ltd have soared today

Challenger Ltd (ASX:CGF) has seen its shares climb more than 4% today.

| More on:

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

Shares in fund manager Challenger Ltd (ASX: CGF) have lifted around 4% today as investors buy into its plans to become one of Australia's premier financial services businesses.

Challenger operates two businesses, a life business and a funds management business.

The life business targets retirees in the drawdown phase of superannuation. This is an increasingly large demographic and Challenger's products are logically popular with those seeking guaranteed cash flows with protection against market, inflation and longevity risks.

In FY14 the group sold $2.8 billion worth of annuity products and sales have grown at a 40% compounded annual growth rate over the past five-year aftermath of the GFC.

The group also has a significant funds management business which is underpinned by the growth in mandatory superannuation contributions over time. The group has around $47 billion in funds under management. This means it is not too far behind rivals like BT Investment Management Ltd (ASX: BTT), which is the funds management arm of Westpac Banking Corp (ASX: WBC).

Challenger also recently announced that retail shareholders on the register as at August 19 have the opportunity to participate in a share purchase plan up to the value of $15,000 at a price which will likely be discounted versus today's prices around $7.74.

Challenger is raising capital to fund APRA's regulatory requirements to maintain capital as its annuities business grows.

The group retains a strong outlook and trades on just 12.8x analysts' forecasts for earnings per share of 60.4 cents in FY15.

At $7.74 Challenger looks to offer some decent value. Buying shares that deliver on value, not price is one of the best ways to deliver growth and is the core strategy of world-famous investors like Warren Buffett.

Motley Fool contributor Tom Richardson has no financial interest in any company mentioned. You can find him on Twitter @tommyr345

More on ⏸️ Investing

A white and black robot in the form of a human being stands in front of a green graphic holding a laptop and discussing robotics and automation ASX shares
Technology Shares

Joining the revolution: How I'd invest in ASX AI shares right now

Advances in artificial intelligence (AI) could usher in a new industrial revolution. Here’s how you can invest in it.

Read more »

Close up of baby looking puzzled
Retail Shares

What has happened to the Baby Bunting (ASX:BBN) share price this year?

It's been a volatile year so far for the Aussie nursery retailer. We take a closer look

Read more »

woman holds sign saying 'we need change' at climate change protest
ETFs

3 ASX ETFs that invest in companies fighting climate change

If you want to shift some of your investments into more ethical companies, exchange-traded funds can offer a good option

Read more »

a jewellery store attendant stands at a cabinet displaying opulent necklaces and earrings featuring diamonds and precious stones.
⏸️ Investing

The Michael Hill (ASX: MHJ) share price poised for growth

Investors will be keeping an eye on the Michael Hill International Limited (ASX: MHJ) share price today. The keen interest…

Read more »

ASX shares buy unstoppable asx share price represented by man in superman cape pointing skyward
⏸️ Investing

The Atomos (ASX:AMS) share price is up 15% in a week

The Atomos (ASX: AMS) share price has surged 15% this week. Let's look at what's ahead as the company build…

Read more »

Two people in suits arm wrestle on a black and white chess board.
Retail Shares

How does the Temple & Webster (ASX:TPW) share price stack up against Nick Scali (ASX:NCK)?

How does the Temple & Webster (ASX: TPW) share price stack up against rival furniture retailer Nick Scali Limited (ASX:…

Read more »

A medical researcher works on a bichip, indicating share price movement in ASX tech companies
Healthcare Shares

The Aroa (ASX:ARX) share price has surged 60% since its IPO

The Aroa (ASX:ARX) share price has surged 60% since the Polynovo (ASX: PNV) competitor listed on the ASX in July.…

Read more »

asx investor daydreaming about US shares
⏸️ How to Invest

How to buy US shares from Australia right now

If you have been wondering how to buy US shares from Australia to gain exposure from the highly topical market,…

Read more »